Abstract:A80 RH1 (2,5-Diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone) is a novel antitumor diaziridinyl benzoquinone derivative designed to be bioactivated by the two-electron reductase, NAD(P)H:quinone oxidoreductase (NQO1), which has been shown to be expressed at high levels in many solid tumors including lung, colon, pancreas and breast. RH1 is a very efficient substrate for NQO1 and reduction by NQO1 to the hydroquinone results in activation of the aziridine rings and subsequent DNA alkylation and interstrand cross linking. The purpose of this study was to investigate whether other reducing enzymes such as cytochrome b5 reductase (b5R), cytochrome P450 reductase (P450R), NRH:quinone oxidoreductase 2 (NQO2), and xanthine oxidoreductase (XDH/XO) were also involved in the bioactivation and cytotoxicity of RH1 in human breast cancer cells. For these studies, we stably transfected the human breast cancer cell line MDA468 with either human NQO1, b5R or P450R and established a series of stable MDA468 cell lines over-expressing various levels of NQO1, b5R and P450R. RH1-induced growth inhibition (MTT analysis) and genotoxicity (interstrand DNA crosslinking/COMET analysis) was then compared in both parental MDA468 cells and transfected clones. RH1 toxicity was significantly higher in NQO1 transfected MDA468 cells (NQ16) compared to parental MDA468 cells, confirming the principal role of NQO1 in the bioactivation and cytotoxicity of RH1. In these studies RH1 cytotoxicity did not correlate with either b5R or P450R activity levels in a series of b5R or P450R over-expressing MDA468 cell clones. An increase in RH1-induced DNA cross-linking was only observed at very high RH1 doses in clones with the highest levels of b5R or P450R activity, suggesting that the role of b5R and P450R in the bioactivation and cytotoxicity of RH1 will be minor in cancer cells with normal levels of b5R and P450R activity. Enzymatic assays and HPLC studies showed that RH1 was an in vitro substrate for both xanthine oxidase and NQO2. However, pretreatment of MDA468 cells with the XO/XDH inhibitor allopurinol failed to protect MDA468 cells from RH1 toxicity, suggesting that XO/XDH is not playing an important role in these cells. Pretreatment of MDA468 cells with NRH, a cofactor for NQO2, significantly increased the toxicity of RH1, suggesting that NQO2 is capable of bioactivating RH1 in cells in the presence of cofactor. Whether NQO2 is involved in RH1 bioactivation in vivo still remains unclear and will depend on the availability of co-factor in vivo. While these studies suggest that NQO1 is the principal enzyme responsible for RH1 bioactivation and that b5R, P450R and XDH/XO are unlikely to play major roles, they do not rule out a role for additional pathways, including NQO2, in RH1 cytotoxicity.

Effect of inducible nitric oxide synthase (iNOS) on chemosensitivity of a breast cancer cell MDA-MB-231~(wt)

[Effect of Inducible Nitric Oxide Synthase on Tumour Cells Sensitivity to Mitomycin C Analogue 629 in Vitro].

Nicotinamide N -methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization

Effects of inducible nitric oxide synthase on tumorigenesis and biological characteristics in human oral cancer cell

The Study on the Effect of Inducible Nitric Oxide Synthase on Tumour Cells Sensitivity to Indoquinine-based Compounds

Effects of NO on Tumour Cells Radiosensitivity to Γ-Rays in Vitro

Nitric Oxide Induces Oral Squamous Cell Carcinoma Cells Apoptosis with P53 Accumulation.

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Effects of Inos on Radiosensitization of AQ4N in Vitro

Dissecting The Role Of Multiple Reductases In Bioactivation And Cytotoxicity Of The Antitumor Agent 2,5-Diaziridinyl-3-(Hydroxymethyl)-6-Methyl-1,4-Benzoquinone (Rh1)

Dissecting the role of multiple reductases in activation and cytotoxicity of RH1

A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer

Nitidine chloride induces apoptosis, cell cycle arrest, and synergistic cytotoxicity with doxorubicin in breast cancer cells

Selective Induction of Tumor Cell Apoptosis by a Novel P450-mediated Reactive Oxygen Species (ROS) Inducer Methyl 3-(4-Nitrophenyl) Propiolate

Unveiling the significance of inducible nitric oxide synthase: its impact on cancer progression and clinical implications

Nanoparticle-induced chemoresistance: the emerging modulatory effects of engineered nanomaterials on human intestinal cancer cell redox metabolic adaptation

Knockdown of ROS1 gene sensitizes breast tumor growth to doxorubicin in a syngeneic mouse model

Pro-Tumor Activity of Endogenous Nitric Oxide in Anti-Tumor Photodynamic Therapy: Recently Recognized Bystander Effects

Abstract IA23: "NO Target for Cancer Stem Cells"

Increased Chemosensitivity and Radiosensitivity of Human Breast Cancer Cell Lines Treated with Novel Functionalized Single-Walled Carbon Nanotubes

Hypoxia-selective cytotoxicity and radiosensitization of quinoxaline 1,4-di-N-oxide derivative, QN-2013